Real world treatment patterns in chronic myeloid leukemia patients newly initiated on tyrosine kinase inhibitors in an U.S. integrated healthcare system. [electronic resource]
Producer: 20180821Description: 253-263 p. digitalISSN:- 1477-092X
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Cohort Studies
- Dasatinib -- therapeutic use
- Databases, Factual
- Delivery of Health Care, Integrated -- methods
- Female
- Humans
- Imatinib Mesylate -- therapeutic use
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Logistic Models
- Male
- Middle Aged
- Protein Kinase Inhibitors -- therapeutic use
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyridines -- therapeutic use
- Pyrimidines -- therapeutic use
- Registries
- Retrospective Studies
- United States -- epidemiology
- Young Adult
No physical items for this record
Publication Type: Journal Article; Pragmatic Clinical Trial
There are no comments on this title.
Log in to your account to post a comment.